The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Bacteriophage Therapy Market Research Report 2025

Global Bacteriophage Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1927654

No of Pages : 108

Ask Your Query

Synopsis

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

The global Bacteriophage Therapy market was valued at US$ 32 million in 2023 and is anticipated to reach US$ 62 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Bacteriophage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage Therapy.

Report Scope

The Bacteriophage Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacteriophage Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bacteriophage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Armata Pharmaceuticals, Inc.
  • Eliava Biopreparations Ltd.
  • Pherecydes Pharma
  • Intralytix, Inc.
  • Phagelux Inc.
  • Nextbiotics
  • InnoPhage, Ltd
  • Locus Biosciences, Inc.
  • TechnoPhage
  • Eligo Bioscience SA
  • Phagomed Biopharma GmbH.
  • PhagePro, Inc.
  • Adaptive Phage Therapeutics, Inc.
  • EnBiotix, Inc.
  • Intodeworld, Inc.
  • BiomX Ltd.
  • Phi Therapeutics
  • Fixed-phage Ltd.
  • Micreos BV
  • ContraFect Corporation

Segment by Type

  • Oral
  • Topical
  • Parenteral

Segment by Application

  • Organ Transplantation
  • Bacterial Infections
  • Alcoholic Hepatitis
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacteriophage Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacteriophage Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Topical
1.2.4 Parenteral
1.3 Market by Application
1.3.1 Global Bacteriophage Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Organ Transplantation
1.3.3 Bacterial Infections
1.3.4 Alcoholic Hepatitis
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bacteriophage Therapy Market Perspective (2019-2030)
2.2 Bacteriophage Therapy Growth Trends by Region
2.2.1 Global Bacteriophage Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bacteriophage Therapy Historic Market Size by Region (2019-2024)
2.2.3 Bacteriophage Therapy Forecasted Market Size by Region (2025-2030)
2.3 Bacteriophage Therapy Market Dynamics
2.3.1 Bacteriophage Therapy Industry Trends
2.3.2 Bacteriophage Therapy Market Drivers
2.3.3 Bacteriophage Therapy Market Challenges
2.3.4 Bacteriophage Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bacteriophage Therapy Players by Revenue
3.1.1 Global Top Bacteriophage Therapy Players by Revenue (2019-2024)
3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bacteriophage Therapy Revenue
3.4 Global Bacteriophage Therapy Market Concentration Ratio
3.4.1 Global Bacteriophage Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacteriophage Therapy Revenue in 2023
3.5 Bacteriophage Therapy Key Players Head office and Area Served
3.6 Key Players Bacteriophage Therapy Product Solution and Service
3.7 Date of Enter into Bacteriophage Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bacteriophage Therapy Breakdown Data by Type
4.1 Global Bacteriophage Therapy Historic Market Size by Type (2019-2024)
4.2 Global Bacteriophage Therapy Forecasted Market Size by Type (2025-2030)
5 Bacteriophage Therapy Breakdown Data by Application
5.1 Global Bacteriophage Therapy Historic Market Size by Application (2019-2024)
5.2 Global Bacteriophage Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bacteriophage Therapy Market Size (2019-2030)
6.2 North America Bacteriophage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bacteriophage Therapy Market Size by Country (2019-2024)
6.4 North America Bacteriophage Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bacteriophage Therapy Market Size (2019-2030)
7.2 Europe Bacteriophage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bacteriophage Therapy Market Size by Country (2019-2024)
7.4 Europe Bacteriophage Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bacteriophage Therapy Market Size (2019-2030)
8.2 Asia-Pacific Bacteriophage Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bacteriophage Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Bacteriophage Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bacteriophage Therapy Market Size (2019-2030)
9.2 Latin America Bacteriophage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bacteriophage Therapy Market Size by Country (2019-2024)
9.4 Latin America Bacteriophage Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bacteriophage Therapy Market Size (2019-2030)
10.2 Middle East & Africa Bacteriophage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bacteriophage Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Bacteriophage Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Armata Pharmaceuticals, Inc.
11.1.1 Armata Pharmaceuticals, Inc. Company Detail
11.1.2 Armata Pharmaceuticals, Inc. Business Overview
11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Introduction
11.1.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2019-2024)
11.1.5 Armata Pharmaceuticals, Inc. Recent Development
11.2 Eliava Biopreparations Ltd.
11.2.1 Eliava Biopreparations Ltd. Company Detail
11.2.2 Eliava Biopreparations Ltd. Business Overview
11.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Introduction
11.2.4 Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2019-2024)
11.2.5 Eliava Biopreparations Ltd. Recent Development
11.3 Pherecydes Pharma
11.3.1 Pherecydes Pharma Company Detail
11.3.2 Pherecydes Pharma Business Overview
11.3.3 Pherecydes Pharma Bacteriophage Therapy Introduction
11.3.4 Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2019-2024)
11.3.5 Pherecydes Pharma Recent Development
11.4 Intralytix, Inc.
11.4.1 Intralytix, Inc. Company Detail
11.4.2 Intralytix, Inc. Business Overview
11.4.3 Intralytix, Inc. Bacteriophage Therapy Introduction
11.4.4 Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2019-2024)
11.4.5 Intralytix, Inc. Recent Development
11.5 Phagelux Inc.
11.5.1 Phagelux Inc. Company Detail
11.5.2 Phagelux Inc. Business Overview
11.5.3 Phagelux Inc. Bacteriophage Therapy Introduction
11.5.4 Phagelux Inc. Revenue in Bacteriophage Therapy Business (2019-2024)
11.5.5 Phagelux Inc. Recent Development
11.6 Nextbiotics
11.6.1 Nextbiotics Company Detail
11.6.2 Nextbiotics Business Overview
11.6.3 Nextbiotics Bacteriophage Therapy Introduction
11.6.4 Nextbiotics Revenue in Bacteriophage Therapy Business (2019-2024)
11.6.5 Nextbiotics Recent Development
11.7 InnoPhage, Ltd
11.7.1 InnoPhage, Ltd Company Detail
11.7.2 InnoPhage, Ltd Business Overview
11.7.3 InnoPhage, Ltd Bacteriophage Therapy Introduction
11.7.4 InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2019-2024)
11.7.5 InnoPhage, Ltd Recent Development
11.8 Locus Biosciences, Inc.
11.8.1 Locus Biosciences, Inc. Company Detail
11.8.2 Locus Biosciences, Inc. Business Overview
11.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Introduction
11.8.4 Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2019-2024)
11.8.5 Locus Biosciences, Inc. Recent Development
11.9 TechnoPhage
11.9.1 TechnoPhage Company Detail
11.9.2 TechnoPhage Business Overview
11.9.3 TechnoPhage Bacteriophage Therapy Introduction
11.9.4 TechnoPhage Revenue in Bacteriophage Therapy Business (2019-2024)
11.9.5 TechnoPhage Recent Development
11.10 Eligo Bioscience SA
11.10.1 Eligo Bioscience SA Company Detail
11.10.2 Eligo Bioscience SA Business Overview
11.10.3 Eligo Bioscience SA Bacteriophage Therapy Introduction
11.10.4 Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2019-2024)
11.10.5 Eligo Bioscience SA Recent Development
11.11 Phagomed Biopharma GmbH.
11.11.1 Phagomed Biopharma GmbH. Company Detail
11.11.2 Phagomed Biopharma GmbH. Business Overview
11.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Introduction
11.11.4 Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2019-2024)
11.11.5 Phagomed Biopharma GmbH. Recent Development
11.12 PhagePro, Inc.
11.12.1 PhagePro, Inc. Company Detail
11.12.2 PhagePro, Inc. Business Overview
11.12.3 PhagePro, Inc. Bacteriophage Therapy Introduction
11.12.4 PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2019-2024)
11.12.5 PhagePro, Inc. Recent Development
11.13 Adaptive Phage Therapeutics, Inc.
11.13.1 Adaptive Phage Therapeutics, Inc. Company Detail
11.13.2 Adaptive Phage Therapeutics, Inc. Business Overview
11.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Introduction
11.13.4 Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2019-2024)
11.13.5 Adaptive Phage Therapeutics, Inc. Recent Development
11.14 EnBiotix, Inc.
11.14.1 EnBiotix, Inc. Company Detail
11.14.2 EnBiotix, Inc. Business Overview
11.14.3 EnBiotix, Inc. Bacteriophage Therapy Introduction
11.14.4 EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2019-2024)
11.14.5 EnBiotix, Inc. Recent Development
11.15 Intodeworld, Inc.
11.15.1 Intodeworld, Inc. Company Detail
11.15.2 Intodeworld, Inc. Business Overview
11.15.3 Intodeworld, Inc. Bacteriophage Therapy Introduction
11.15.4 Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2019-2024)
11.15.5 Intodeworld, Inc. Recent Development
11.16 BiomX Ltd.
11.16.1 BiomX Ltd. Company Detail
11.16.2 BiomX Ltd. Business Overview
11.16.3 BiomX Ltd. Bacteriophage Therapy Introduction
11.16.4 BiomX Ltd. Revenue in Bacteriophage Therapy Business (2019-2024)
11.16.5 BiomX Ltd. Recent Development
11.17 Phi Therapeutics
11.17.1 Phi Therapeutics Company Detail
11.17.2 Phi Therapeutics Business Overview
11.17.3 Phi Therapeutics Bacteriophage Therapy Introduction
11.17.4 Phi Therapeutics Revenue in Bacteriophage Therapy Business (2019-2024)
11.17.5 Phi Therapeutics Recent Development
11.18 Fixed-phage Ltd.
11.18.1 Fixed-phage Ltd. Company Detail
11.18.2 Fixed-phage Ltd. Business Overview
11.18.3 Fixed-phage Ltd. Bacteriophage Therapy Introduction
11.18.4 Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2019-2024)
11.18.5 Fixed-phage Ltd. Recent Development
11.19 Micreos BV
11.19.1 Micreos BV Company Detail
11.19.2 Micreos BV Business Overview
11.19.3 Micreos BV Bacteriophage Therapy Introduction
11.19.4 Micreos BV Revenue in Bacteriophage Therapy Business (2019-2024)
11.19.5 Micreos BV Recent Development
11.20 ContraFect Corporation
11.20.1 ContraFect Corporation Company Detail
11.20.2 ContraFect Corporation Business Overview
11.20.3 ContraFect Corporation Bacteriophage Therapy Introduction
11.20.4 ContraFect Corporation Revenue in Bacteriophage Therapy Business (2019-2024)
11.20.5 ContraFect Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Bacteriophage Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Topical
Table 4. Key Players of Parenteral
Table 5. Global Bacteriophage Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Bacteriophage Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Bacteriophage Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Bacteriophage Therapy Market Share by Region (2019-2024)
Table 9. Global Bacteriophage Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Bacteriophage Therapy Market Share by Region (2025-2030)
Table 11. Bacteriophage Therapy Market Trends
Table 12. Bacteriophage Therapy Market Drivers
Table 13. Bacteriophage Therapy Market Challenges
Table 14. Bacteriophage Therapy Market Restraints
Table 15. Global Bacteriophage Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Bacteriophage Therapy Market Share by Players (2019-2024)
Table 17. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2023)
Table 18. Ranking of Global Top Bacteriophage Therapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Bacteriophage Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bacteriophage Therapy Product Solution and Service
Table 22. Date of Enter into Bacteriophage Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bacteriophage Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Bacteriophage Therapy Revenue Market Share by Type (2019-2024)
Table 26. Global Bacteriophage Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Bacteriophage Therapy Revenue Market Share by Type (2025-2030)
Table 28. Global Bacteriophage Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Bacteriophage Therapy Revenue Market Share by Application (2019-2024)
Table 30. Global Bacteriophage Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Bacteriophage Therapy Revenue Market Share by Application (2025-2030)
Table 32. North America Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Bacteriophage Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Bacteriophage Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Bacteriophage Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Bacteriophage Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Bacteriophage Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Bacteriophage Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Bacteriophage Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Bacteriophage Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Bacteriophage Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Bacteriophage Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Bacteriophage Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Armata Pharmaceuticals, Inc. Company Detail
Table 48. Armata Pharmaceuticals, Inc. Business Overview
Table 49. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product
Table 50. Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 51. Armata Pharmaceuticals, Inc. Recent Development
Table 52. Eliava Biopreparations Ltd. Company Detail
Table 53. Eliava Biopreparations Ltd. Business Overview
Table 54. Eliava Biopreparations Ltd. Bacteriophage Therapy Product
Table 55. Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 56. Eliava Biopreparations Ltd. Recent Development
Table 57. Pherecydes Pharma Company Detail
Table 58. Pherecydes Pharma Business Overview
Table 59. Pherecydes Pharma Bacteriophage Therapy Product
Table 60. Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 61. Pherecydes Pharma Recent Development
Table 62. Intralytix, Inc. Company Detail
Table 63. Intralytix, Inc. Business Overview
Table 64. Intralytix, Inc. Bacteriophage Therapy Product
Table 65. Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 66. Intralytix, Inc. Recent Development
Table 67. Phagelux Inc. Company Detail
Table 68. Phagelux Inc. Business Overview
Table 69. Phagelux Inc. Bacteriophage Therapy Product
Table 70. Phagelux Inc. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 71. Phagelux Inc. Recent Development
Table 72. Nextbiotics Company Detail
Table 73. Nextbiotics Business Overview
Table 74. Nextbiotics Bacteriophage Therapy Product
Table 75. Nextbiotics Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 76. Nextbiotics Recent Development
Table 77. InnoPhage, Ltd Company Detail
Table 78. InnoPhage, Ltd Business Overview
Table 79. InnoPhage, Ltd Bacteriophage Therapy Product
Table 80. InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 81. InnoPhage, Ltd Recent Development
Table 82. Locus Biosciences, Inc. Company Detail
Table 83. Locus Biosciences, Inc. Business Overview
Table 84. Locus Biosciences, Inc. Bacteriophage Therapy Product
Table 85. Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 86. Locus Biosciences, Inc. Recent Development
Table 87. TechnoPhage Company Detail
Table 88. TechnoPhage Business Overview
Table 89. TechnoPhage Bacteriophage Therapy Product
Table 90. TechnoPhage Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 91. TechnoPhage Recent Development
Table 92. Eligo Bioscience SA Company Detail
Table 93. Eligo Bioscience SA Business Overview
Table 94. Eligo Bioscience SA Bacteriophage Therapy Product
Table 95. Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 96. Eligo Bioscience SA Recent Development
Table 97. Phagomed Biopharma GmbH. Company Detail
Table 98. Phagomed Biopharma GmbH. Business Overview
Table 99. Phagomed Biopharma GmbH. Bacteriophage Therapy Product
Table 100. Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 101. Phagomed Biopharma GmbH. Recent Development
Table 102. PhagePro, Inc. Company Detail
Table 103. PhagePro, Inc. Business Overview
Table 104. PhagePro, Inc. Bacteriophage Therapy Product
Table 105. PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 106. PhagePro, Inc. Recent Development
Table 107. Adaptive Phage Therapeutics, Inc. Company Detail
Table 108. Adaptive Phage Therapeutics, Inc. Business Overview
Table 109. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product
Table 110. Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 111. Adaptive Phage Therapeutics, Inc. Recent Development
Table 112. EnBiotix, Inc. Company Detail
Table 113. EnBiotix, Inc. Business Overview
Table 114. EnBiotix, Inc. Bacteriophage Therapy Product
Table 115. EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 116. EnBiotix, Inc. Recent Development
Table 117. Intodeworld, Inc. Company Detail
Table 118. Intodeworld, Inc. Business Overview
Table 119. Intodeworld, Inc. Bacteriophage Therapy Product
Table 120. Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 121. Intodeworld, Inc. Recent Development
Table 122. BiomX Ltd. Company Detail
Table 123. BiomX Ltd. Business Overview
Table 124. BiomX Ltd. Bacteriophage Therapy Product
Table 125. BiomX Ltd. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 126. BiomX Ltd. Recent Development
Table 127. Phi Therapeutics Company Detail
Table 128. Phi Therapeutics Business Overview
Table 129. Phi Therapeutics Bacteriophage Therapy Product
Table 130. Phi Therapeutics Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 131. Phi Therapeutics Recent Development
Table 132. Fixed-phage Ltd. Company Detail
Table 133. Fixed-phage Ltd. Business Overview
Table 134. Fixed-phage Ltd. Bacteriophage Therapy Product
Table 135. Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 136. Fixed-phage Ltd. Recent Development
Table 137. Micreos BV Company Detail
Table 138. Micreos BV Business Overview
Table 139. Micreos BV Bacteriophage Therapy Product
Table 140. Micreos BV Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 141. Micreos BV Recent Development
Table 142. ContraFect Corporation Company Detail
Table 143. ContraFect Corporation Business Overview
Table 144. ContraFect Corporation Bacteriophage Therapy Product
Table 145. ContraFect Corporation Revenue in Bacteriophage Therapy Business (2019-2024) & (US$ Million)
Table 146. ContraFect Corporation Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacteriophage Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Bacteriophage Therapy Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Topical Features
Figure 5. Parenteral Features
Figure 6. Global Bacteriophage Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Bacteriophage Therapy Market Share by Application: 2023 VS 2030
Figure 8. Organ Transplantation Case Studies
Figure 9. Bacterial Infections Case Studies
Figure 10. Alcoholic Hepatitis Case Studies
Figure 11. Other Case Studies
Figure 12. Bacteriophage Therapy Report Years Considered
Figure 13. Global Bacteriophage Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Bacteriophage Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Bacteriophage Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Bacteriophage Therapy Market Share by Players in 2023
Figure 17. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Bacteriophage Therapy Revenue in 2023
Figure 19. North America Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Bacteriophage Therapy Market Share by Country (2019-2030)
Figure 21. United States Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Bacteriophage Therapy Market Share by Country (2019-2030)
Figure 25. Germany Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Bacteriophage Therapy Market Share by Region (2019-2030)
Figure 33. China Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Bacteriophage Therapy Market Share by Country (2019-2030)
Figure 41. Mexico Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Bacteriophage Therapy Market Share by Country (2019-2030)
Figure 45. Turkey Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Bacteriophage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 48. Eliava Biopreparations Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 49. Pherecydes Pharma Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 50. Intralytix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 51. Phagelux Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 52. Nextbiotics Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 53. InnoPhage, Ltd Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 54. Locus Biosciences, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 55. TechnoPhage Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 56. Eligo Bioscience SA Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 57. Phagomed Biopharma GmbH. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 58. PhagePro, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 59. Adaptive Phage Therapeutics, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 60. EnBiotix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 61. Intodeworld, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 62. BiomX Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 63. Phi Therapeutics Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 64. Fixed-phage Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 65. Micreos BV Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 66. ContraFect Corporation Revenue Growth Rate in Bacteriophage Therapy Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock